文献速递肺外科

五例原发性肺癌合并SARS-CoV-2感染手术患者的临床过程与结局

Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

该回顾性研究评估了5例在SARS-CoV-2感染期间接受原发性肺癌手术的成人患者,均为男性,平均年龄74.0岁。手术包括微创肺叶切除、肺段切除、肺叶切除加胸壁整块切除及全肺切除。手术相关并发症发生率为60%,30天死亡率为40%,2例死于SARS-CoV-2相关呼吸衰竭。

要点

  • 肺癌手术可能是发展为重症COVID-19的高危因素,尤其晚期肺癌患者。
  • 5例患者中手术相关并发症发生率60%,30天死亡率40%。
  • 需额外策略降低肺癌治疗期间SARS-CoV-2感染的发病和死亡风险。

核心结论

  • 肺癌手术可能是发展为重症COVID-19的高危因素,特别是晚期肺癌患者。
  • 需要额外策略以降低肺癌治疗期间SARS-CoV-2感染的发病率和死亡率。

研究设计与样本

  • 回顾性评估2020年1月29日至3月4日期间因原发性肺癌手术而入住胸外科的5例SARS-CoV-2感染成人患者。

主要发现

  • 所有患者均为男性,平均年龄74.0岁(范围67-80)。
  • 5例中4例(80%)报告慢性合并症。
  • 手术包括微创肺叶切除(2例)、肺段切除(1例)、肺叶切除加胸壁整块切除(1例)和全肺切除(1例)。
  • 平均胸管留置时间12.4天(范围8-22),平均住院时间33.8天(范围21-60)。
  • SARS-CoV-2相关症状包括发热(3例)、持续咳嗽(3例)、腹泻(2例)和晕厥(2例),1例无症状。

临床怎么用

  • 对合并SARS-CoV-2感染的肺癌患者,手术决策需权衡高并发症和死亡风险。
  • 术后应密切监测SARS-CoV-2相关呼吸衰竭,尤其高龄、有合并症及晚期肺癌患者。

局限性

  • 样本量小(5例),为单中心回顾性研究,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is currently a lack of clinical data on the novel beta-coronavirus infection [caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] and concomitant primary lung cancer. Our goal was to report our experiences with 5 patients treated for lung cancer while infected with SARS-CoV-2. METHODS: We retrospectively evaluated 5 adult patients infected with SARS-CoV-2 who were admitted to our thoracic surgery unit between 29 January 2020 and 4 March 2020 for surgical treatment of a primary lung cancer. Clinical data and outcomes are reported. RESULTS: All patients were men with a mean age of 74.0 years (range 67-80). Four of the 5 patients (80%) reported chronic comorbidities. Surgery comprised minimally invasive lobectomy (2 patients) and segmentectomy (1 patient), lobectomy with en bloc chest wall resection (1 patient) and pneumonectomy (1 patient). Mean chest drain duration was 12.4 days (range 8-22); mean hospital stay was 33.8 days (range 21-60). SARS-CoV-2-related symptoms were fever (3 patients), persistent cough (3 patients), diarrhoea (2 patients) and syncope (2 patients); 1 patient reported no symptoms. Morbidity related to surgery was 60%; 30-day mortality was 40%. Two patients (1 with a right pneumonectomy, 74 years old; 1 with a lobectomy with chest wall resection and reconstruction, 70 years old), developed SARS-CoV-2-related lung failure leading to death 60 and 32 days after surgery, respectively. CONCLUSIONS: Lung cancer surgery may represent a high-risk factor for developing a severe case of coronavirus disease 2019, particularly in patients with advanced stages of lung cancer. Additional strategies are needed to reduce the risk of morbidity and mortality from SARS-CoV-2 infection during treatment for lung cancer.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gonfiotti A, Gatteschi L, Salvicchi A, et al. Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2. Eur J Cardiothorac Surg. 2020. PMID: 32856063. doi:10.1093/ejcts/ezaa233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。